An amino acid derivative resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of valine by a heteroatom. The definition normally excludes peptides containing valine residues.
ChEBI ID: 27267
| Member | Definition | Role |
|---|---|---|
| 2-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-N-(6-methoxy-1,3-benzothiazol-2-yl)-3-methylbutanamide | 2-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-N-(6-methoxy-1,3-benzothiazol-2-yl)-3-methylbutanamide | |
| bms-790052 | A member of the class of biphenyls that is a potent inhibitor of nonstructural protein 5A and is used (as its hydrochloride salt) for treatment of hepatitis C. | daclatasvir |
| iprovalicarb | A carbamate ester that is valinamide in which one of the hydrogens attached to the amide nitrogen is replaced by a 1-(p-tolyl)ethyl group and the alpha-amino group has been converted to the corresponding isopropyl carbamate. | isopropyl (3-methyl-1-{[1-(4-methylphenyl)ethyl]amino}-1-oxobutan-2-yl)carbamate |
| n-methylvaline | An N-methylamino acid that is the N-methyl derivative of valine. | N-methylvaline |
| penicillamine disulfide | Penicillamine disulfide |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 10 (1.31) | 18.7374 |
| 1990's | 4 (0.52) | 18.2507 |
| 2000's | 10 (1.31) | 29.6817 |
| 2010's | 596 (78.11) | 24.3611 |
| 2020's | 143 (18.74) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 120 (15.02%) | 5.53% |
| Reviews | 86 (10.76%) | 6.00% |
| Case Studies | 59 (7.38%) | 4.05% |
| Observational | 50 (6.26%) | 0.25% |
| Other | 484 (60.58%) | 84.16% |